Nuvectis Pharma (NVCT) Change in Account Payables (2023 - 2026)
Nuvectis Pharma (NVCT) reported Change in Account Payables of -$1.6 million for Q1 2026, down 419.64% on a YoY basis from $494000.0 in Q1 2025, and down 856.97% sequentially from -$165000.0 in Q4 2025.
Nuvectis Pharma (NVCT) Change in Account Payables (2023 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 4 years of Change in Account Payables data on file, last reported at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 419.64% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 38.12% YoY), and the FY2025 full-year result was $3.8 million, up 1483.15% from the prior year.
- Change in Account Payables eased to -$1.6 million in Q1 2026, from -$165000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q2 2025 to a low of -$1.6 million in Q1 2026.
- A 4-year average of $137307.7 and a median of $87000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 2181.61% in 2025 and plunged 419.64% in 2026, its largest moves.
- Tracing NVCT's Change in Account Payables over 4 years: stood at -$721000.0 in 2023, then jumped by 132.87% to $237000.0 in 2024, then sank by 169.62% to -$165000.0 in 2025, then tumbled by 856.97% to -$1.6 million in 2026.
- Business Quant data shows NVCT's Change in Account Payables at -$1.6 million in Q1 2026, -$165000.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Nuvectis Pharma | 471.80 Mn | 471.80 Mn | - | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.58 Mn |
| Mar 31, 2026 | -1.58 Mn |
| Dec 31, 2025 | -165,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 494,000.00 |
| Mar 31, 2025 | 494,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | -1.01 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | -721,000.00 |
| Dec 31, 2023 | -721,000.00 |